Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma

Diseases of the Esophagus

Volumn 23, Issue 7, 2010, Pages 580-589

  Bobryshev, Y V ^a   Freeman, A K ^a   Botelho, N K ^a   Tran, D ^a   Levert Mignon, A J M ^a   Lord, R V N ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Barrett's esophagus; Cancer stem cells; Dendritic cells; Esophageal adenocarcinoma; Musashi 1

Indexed keywords

CD209 ANTIGEN; CELL MARKER; INTERCELLULAR ADHESION MOLECULE 3; MESSENGER RNA; PROTEIN MUSASHI 1; RNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BARRETT ESOPHAGUS; CANCER STEM CELL; CELL PROLIFERATION; CLINICAL ARTICLE; DENDRITIC CELL; EPITHELIUM CELL; ESOPHAGEAL ADENOCARCINOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS EPITHELIUM;

ADENOCARCINOMA; BARRETT ESOPHAGUS; ESOPHAGEAL NEOPLASMS; HUMANS; NERVE TISSUE PROTEINS; RNA-BINDING PROTEINS;

EID: 77957167403     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2010.01061.x     Document Type: Article

References (50)

1. Mantovani A, Allavena P, Sica A. Cancer-related inflammation. Nature 2008, 454:436-44.
2. O'Byrne K J, Dalgleish A G. Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer 2001, 85:473-83.
3. Macarthur M, Hold G L, El-Omar E M. Inflammation and Cancer II. Role of chronic inflammation and cytokine gene polymorphisms in the pathogenesis of gastrointestinal malignancy. Am J Physiol Gastrointest Liver Physiol 2004, 286:G515-20.
4. Moons L M, Kusters J G, Bultman E. Barrett's oesophagus is characterized by a predominantly humoral inflammatory response. J Pathol 2005, 207:269-76.
5. Abdel-Latif M M, Duggan S, Reynolds J V. Inflammation and esophageal carcinogenesis. Curr Opin Pharmacol 2009, 9:396-404.
6. Oberg S, Peters J H, DeMeester T R. Inflammation and specialized intestinal metaplasia of cardiac mucosa is a manifestation of gastroesophageal reflux disease. Ann Surg 1997, 226:522-30.
7. Der R, Tsao-Wei D D, DeMeester T. Carditis: a manifestation of gastroesophageal reflux disease. Am J Surg Pathol 2001, 25:245-52.
8. Bobryshev Y V, Tran D, Killingsworth M C. Dendritic cell-associated immune inflammation of cardiac mucosa: a possible factor in the formation of Barrett's esophagus. J Gastrointest Surg 2009, 13:442-50.
9. Bobryshev Y V, Tran D, Killingsworth M C. Dendritic cells in Barrett's esophagus and esophageal adenocarcinoma. J Gastrointest Surg 2009, 13:44-53.
10. van de Ven R, Scheffer G L, Scheper R J. The ABC of dendritic cell development and function. Trends Immunol 2009, 30:421-9.
11. Quante M, Wang T C. Inflammation and stem cells in gastrointestinal carcinogenesis. Physiology 2008, 23:350-9.
12. Visvader J E, Lindeman G J. Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer 2008, 8:755-68.
13. Zou G M. Cancer initiating cells or cancer stem cells in the gastrointestinal tract and liver. J Cell Physiol 2008, 217:598-604.
14. Cho R W, Clarke M F. Recent advances in cancer stem cells. Curr Opin Genet Dev 2008, 18:48-53.
15. Phesse T J, Clarke A R. Normal stem cells in cancer prone epithelial tissues. Br J Cancer 2009, 100:221-7.
16. Barker N, Ridgway R A, van Es J H. Crypt stem cells as the cells-of-origin of intestinal cancer. Nature 2009, 457:608-11.
17. Brabletz S, Schmalhofer O, Brabletz T. Gastrointestinal stem cells in development and cancer. J Pathol 2009, 217:307-17.
18. Lord R V. Genetic basis of the Barrett's metaplasia, dysplasia, adenocarcinoma sequence. Probl Gen Surg 2001, 18:53-70.
19. Peters C J, Fitzgerald R C. Systematic review: the application of molecular pathogenesis to prevention and treatment of oesophageal adenocarcinoma. Aliment Pharmacol Ther 2007, 25:1253-69.
20. Rindi G, Bishop A E, Daly M J. A mixed pattern of endocrine cells in metaplastic Barrett's oesophagus. Evidence that the epithelium derives from a pluripotential stem cell. Histochemistry 1987, 87:377-83.
21. Jankowski J A, Harrison R F, Perry I. Barrett's metaplasia. Lancet 2000, 356:2079-85.
22. Suo Z, Nesland J M. Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells. Ultrastruct Pathol 2002, 26:53-4.
23. Seery J P. Stem cells of the oesophageal epithelium. J Cell Sci 2002, 115:1783-9. Pt 9
24. Seery J P, Watt F M. Asymmetric stem-cell divisions define the architecture of human oesophageal epithelium. Curr Biol 2000, 10:1447-50.
25. Leedham S J, Preston S L, McDonald S A. Individual crypt genetic heterogeneity and the origin of metaplastic glandular epithelium in human Barrett's oesophagus. Gut 2008, 57:1041-8.
26. Spechler S J, Souza R F. Stem cells in Barrett's esophagus: HALOs or horns? Gastrointest Endosc 2008, 68:41-3.
27. van Dekken H, Vissers C J, Tilanus H W. Clonal analysis of a case of multifocal oesophageal (Barrett's) adenocarcinoma by comparative genomic hybridization. J Pathol 1999, 188:263-6.
28. Okano H, Kawahara H, Toriya M. Function of RNA-binding protein Musashi-1 in stem cells. Exp Cell Res 2005, 306:349-56.
29. Potten C S, Booth C, Tudor G L. Identification of a putative intestinal stem cell and early lineage marker; musashi-1. Differentiation 2003, 71:28-41.
30. Montgomery R K, Breault D T. Small intestinal stem cell markers. J Anat 2008, 213:52-8.
31. Yen T H, Wright N A. The gastrointestinal tract stem cell niche. Stem Cell Rev 2006, 2:203-12.
32. Schulenburg A, Cech P, Herbacek I. CD44-positive colorectal adenoma cells express the potential stem cell markers musashi antigen (msi1) and ephrin B2 receptor (EphB2). J Pathol 2007, 213:152-60.
33. Fan L-F, Dong W-G, Jiang C-Q. Expression of putative stem cell genes Musashi-1 and β1-integrin in human colorectal adenomas and adenocarcinomas. Int J Colorectal Dis 2010, 25:17-23.
34. Geijtenbeek T B, Torensma R, van Vliet S J. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000, 100:575-85.
35. Lechmann M, Krooshoop D J, Dudziak D. The extracellular domain of CD83 inhibits dendritic cell-mediated T cell stimulation and binds to a ligand on dendritic cells. J Exp Med 2001, 194:1813-21.
36. Stanley K K, Szewczuk E. Multiplexed tandem PCR: gene profiling from small amounts of RNA using SYBR Green detection. Nucleic Acids Res 2005, 33:e180.
37. Todaro M, Perez Alea M, Scopelliti A. IL-4-mediated drug resistance in colon cancer stem cells. Cell Cycle 2008, 7:309-13.
38. Yokota N, Mainprize T G, Taylor M D. Identification of differentially expressed and developmentally regulated genes in medulloblastoma using suppression subtraction hybridization. Oncogene 2004, 23:3444-53.
39. Nakano A, Kanemura Y, Mori K. Expression of the neural RNA-binding protein Musashi1 in pediatric brain tumors. Pediatr Neurosurg 2007, 43:279-84.
40. Toda M, Iizuka Y, Yu W. Expression of the neural RNA-binding protein Musashi1 in human gliomas. Glia 2001, 34:1-7.
41. Kanemura Y, Mori K, Sakakibara S. Musashi1, an evolutionarily conserved neural RNA-binding protein, is a versatile marker of human glioma cells in determining their cellular origin, malignancy, and proliferative activity. Differentiation 2001, 68:141-52.
42. Ma Y H, Mentlein R, Knerlich F. Expression of stem cell markers in human astrocytomas of different WHO grades. J Neurooncol 2008, 86:31-45.
43. Seigel G M, Hackam A S, Ganguly A. Human embryonic and neuronal stem cell markers in retinoblastoma. Mol Vis 2007, 13:823-32.
44. Gotte M, Wolf M, Staebler A. Increased expression of the adult stem cell marker Musashi-1 in endometriosis and endometrial carcinoma. J Pathol 2008, 215:317-29.
45. Shu H J, Saito T, Watanabe H. Expression of the Musashi1 gene encoding the RNA-binding protein in human hepatoma cell lines. Biochem Biophys Res Commun 2002, 293:150-4.
46. Sureban S M, May R, George R J. Knockdown of RNA binding protein musashi-1 leads to tumor regression in vivo. Gastroenterology 2008, 134:1448-58.
47. Clarke R B. Isolation and characterization of human mammary stem cells. Cell Prolif 2005, 38:375-86.
48. Kawakami K, Brabender J, Lord R V. Hypermethylated APC DNA in plasma and prognosis of patients with esophageal adenocarcinoma. J Natl Cancer Inst 2000, 92:1805-11.
49. Srivastava R M, Khar A. Dendritic cells and their receptors in antitumor immune response. Curr Mol Med 2009, 9:708-24.
50. Chaudhuri D, Suriano R, Mittelman A. Targeting the immune system in cancer. Curr Pharm Biotechnol 2009, 10:166-84.